-
Teva reaches proposed $4.35 settlement US opioid lawsuits | Business
ID: lvXrEbNtvJ
From: cnn.com
-
Ex-pharmaceutical company boss faces insider trading charges over Teva deal | The of Israel
ID: Woq6f6QANT
From: timesofisrael.com
-
Why Buffett's Berkshire loathed drug stock
ID: ReODDghuTr
From: cnbc.com
-
Teva's profit beats forecasts, shares jump - Israel News Post
ID: Kw6ikFWNDF
From: jpost.com
-
Israeli drug company reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel
ID: OcNPrquX6Q
From: timesofisrael.com
-
to Cut to 25% Israel Workforce, Calcalist Says - Bloomberg
ID: wgfJAKXLXx
From: bloomberg.com
-
Teva shares amid CEO departure and bribery reports
ID: YU87W0QtIu
From: cnbc.com
-
Teva Shares Progress Toward Access to Medicines and Environmental Commitments, Meeting Exceeding Several ESG Targets Ahead of Schedule | Business Wire
ID: Az7i5gvQCB
From: businesswire.com
-
Teva shed of Israel in two years - Globes
ID: PsqNSo23ka
From: en.globes.co.il
-
In largest acquisition, Teva buys Allergan Generics for $40.5b - The Jerusalem Post
ID: chbpXLd6kt
From: jpost.com
-
Teva Falls Hard, Loses Title as Biggest Firm - TheStreet
ID: 3ajPFFkZzU
From: thestreet.com
-
Teva Stock Price Rises Money Israel
ID: MM9SKjO4ED
From: wisemoneyisrael.com
-
Teva Pharmaceuticals Stock Jumps After Reporting Earnings. What You Need to Know. |
ID: IbQ4ZC7xbu
From: barrons.com
-
Pharmaceutical Industries Ltd. –
ID: ffsGyAug4z
From: artonpapers.com
-
Teva's $40.5B deal
ID: GpSAqaEV0G
From: timesunion.com
-
Teva's shares first beat expectations | The Times of Israel
ID: yNc8EknJtZ
From: timesofisrael.com
-
Israel's PERI Tank on Q4 Earnings; IZRL in Focus - TipRanks.com
ID: ttqbLiu3Hs
From: tipranks.com
-
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/UYYIWER3TJHUVEUM444ZBHVWGM.jpg "stock falls in and New York as CEO 2018 will be a year of falling and profits")
stock falls in and New York as CEO 2018 will be a year of falling and profits
ID: DNETtJZZFD
From: inquirer.com
-
Israel's Teva move HQ from to New Jersey | The Times of
ID: XrF2Ab9t6b
From: timesofisrael.com
-
Teva stock downgraded to neutral by UBS heels of $85 million opioid - MarketWatch
ID: QhToeKcW0h
From: marketwatch.com
-
Teva's Price Surge Against Predictable Woes
ID: vN9hLItU0a
From: forbes.com
-
Warren boosts bet on ailing drugmaker | The Times
ID: 6Zdnt9xS1M
From: timesofisrael.com
-
Teva Stock: What We Know, And Don't, About The Shortage | Investor's Business Daily
ID: GPuEFLqYsF
From: investors.com
-
Teva gives upbeat outlook restructuring proceeds | The Seattle Times
ID: xIfWFNG2qv
From: seattletimes.com